Clinical trials are research studies that test medical, surgical, or behavioral interventions in people. These trials are essential for determining if new treatments or preventions, such as drugs, diets, or medical devices, are safe and effective.
They are critical for introducing innovative treatments to clinicians to assist cancer patients, particularly those who have not had success with standard treatments. There's a significant need to make clinical trials more accessible, especially for patients seeking alternative treatments after exhausting conventional options.
To establish a clinical trial, support from scientists, clinicians, pharmaceutical companies, and academic institutions is required. In British Columbia and across Canada, efforts are being made to increase the number of available clinical trials by collaborating with the "clinical trial ecosystem" to bring more trials to Canada and make them more accessible to local patients.
Currently, a large number of clinical trials are conducted in the US and Europe, creating challenges for Canadian patients wishing to participate. The current Minister of Health in British Columbia has recognized the life science sector as immensely valuable to the province and its future economy. He has also emphasized the importance of increasing access to clinical trials for patients in British Columbia.
Traditionally, companies with potentially therapeutic products had to conduct their clinical trials abroad in countries like the US and Australia. However, British Columbia recently announced a new strategy to establish itself as a leading global hub for life sciences, including a focus on clinical trials as a key component of this initiative.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.